Scancell Share Discussion Threads

[torquayfan] 31/10/2017 14:33

Fragma - why would casual observers be relevant ?
No need to bother - why did you ?
(I can't imagine anyone being a casual observer of SCLP.)
Two Platforms. 6 targets atm. Results observed 'far beyond previous'.
Nothing around 'The Street' where SCLP is concerned. ATB

[fragma] 31/10/2017 12:03

Just a casual observer, Won't bother next time.

[alphapig] 31/10/2017 11:38

It's like the film 'Naked gun' where Drebin asks the street shoe cleaner what the word on the street is, very funny. Unlike here where someone is deliberately trying to get the price further down.

[chelsea35] 31/10/2017 11:37

Well i take it you have sold your shares then!!! Have a good day.

[bermudashorts] 31/10/2017 11:26

fragma - the word from who?

[fragma] 31/10/2017 11:22

A better question would be : why the fall without any sells ?

The brokers/market makers are the first to know and act accordingly !

[chelsea35] 31/10/2017 11:12

panama7, if there was word on the street why post that after the fall??

[panama7] 31/10/2017 10:04

Chelsea, why is it bull$hit, based on what we were told at the AGM would you not expect the share price to be showing an upward trend and more buys then sells.

[chelsea35] 31/10/2017 10:00

fragma, bull 5hit

[panama7] 31/10/2017 09:43

Fragma, you could well be right, no selling yet stock has dropped 7.5 % in 10 mins.

[fragma] 31/10/2017 09:33

Word on the street is a placing at 8.5p

[chelsea35] 31/10/2017 05:08

Morning goosed. Yeah posted that at 10.28 yesterday. Good post.

This was posted by boomorbust yesterday on LSE, a good find, excellent post.

Scancell get a mention in video published today on recent advances in cancer therapies - video below (note this is Zacks coverage)

[gooosed] 30/10/2017 10:16

I don't post on LSE but you/anyone are/is welcome to copy over should you/they wish.

A couple points of interest perhaps. The prominence of Cornelis Melief, Ph.D.,
( ) whom was first highlighted by Boom and Scancells' possible relationship with ISA Pharmaceuticals.

Also of note was the distinction made between vaccines and those incorporating neo-antigens which are fuelling the "renaissance" or so it is mentioned on the novel targets link.

We are all waiting for the world of Oncology to get a look at Moditope - hope the long wait is worth it.

[torquayfan] 30/10/2017 10:05

Thanks Goosed.
I'm not sure that they've seen these links on LSE - if you have time, why not post them over there too ? Nice one.

[gooosed] 30/10/2017 09:47

May be of interest to some :

[gooosed] 30/10/2017 09:24

While waiting for news (hopefully significant) in November - this clip underlines the return of vaccines :

"Studies at MD Anderson are primarily vaccine trials as well as a few looking at checkpoint blockade"



Could Moditope be a candidate for inclusion (in time) together with SCIB1 at MD Anderson.

Roll on 8 Nov

[wigwammer] 27/10/2017 17:42

"Yeah even Wigwammer's keeping his trap shut about his entry point"I only come here when I'm extremely bored.The frequency and longevity of your presence says a lot.

[chelsea35] 27/10/2017 01:12

TF, and i answered it. I said"" I understand fully criticism of RG."", I did not say i shared that criticism. I actually gave a list of news which we would expect to occur in his time left as CEO, which will leave most of us feeling RG has done a very good job. He has steered us through 17 years of service too, just to get us to this place, really hope he does leave his role with the tools which will allow Dr Holloway to hit the ground running.

[torquayfan] 26/10/2017 23:46

Wanderer - it's arguable whether two platforms with patent protection and 6 target indications so far, represents 'zilch' as you say. The breadth, depth and complexity of Scancell's 'on the edge' science is a massive project for a small team. I hope you will be 'eating your words' about RG before too long ?

C7 it's not sweet - just my 'measured' take. You've seen GF's comment on your 'position' on RG, in the other place ?

We are all aware of what 'could occur' before Dr Chris Holloway joins the Scancell team - btw he is not taking the 'Chair' - that remains JC's I believe. And RG will still be around - that's excellent IMO because RG will have myriad insights into the personalities and corporates on the 'scene' and he will be a great help to the new CEO.

GLA

[chelsea35] 26/10/2017 18:25

But it is not only us. Just take a look at IMMs share price five years ago, only a few months ago hitting a low of 20p, whilst IN a Phase 3 trial. Just touching that magic £1 mark now and looking very strong. There was never really much doubt about succeeding in that trial. So from 20p-£1 in months and they were fully funded during that period.

I understand fully criticism of RG. Been a long time since inflection news only to rise on an FT share tip and positive feedback from the AGM, only to drift back with no further momentum news. We can only hope for decent funding news, IND Approval and confirmation of patient recruitment for SCIB1 Combo Trial...............and then of course there is Patent Approval for Moditope and hopefully commercial deal news to follow. Wonder how the share price will perform on those items of news???

TF, you"re baiting of those who are not RGs best fans is very sweet, I prefer to make a case for what could occur before the new CEO takes the chair.

[wanderer1210_0] 26/10/2017 17:11

Lol TF, of course it's AIM, that's how the CEO as got away with "baiting" the market for many years and delivering Zilch, only on AIM would this happen lol

[gazza] 26/10/2017 16:41

Yes I am thank you

[the real lozan] 26/10/2017 15:35

Gash -
I hope / trust, you are fully recovered ???

[torquayfan] 26/10/2017 14:47

Tosh you really do see things in the worst of all possible lights whenever you think you can get away with it - I'm not suggesting there is any insight, reason or strategy in your 'approach'. I listened again to the AGM recording and for me there was much to be reassured about.

The sentiment is not negative - it's the AIM market.

Great post from Steve 67 on LSE and I apologise to him for quoting ''7k GBP of sales and we lose 1M GBP MCAP! At this rate, if someone sells 243k GBP we'd have an share price & MCAP of 0!'' Tosh the volumes of sales are tiny.

Sentiment is fine M8 - AIM ain't.

Of course we wait eagerly for news of the Moditope Patent and a deal at some stage.

Patience - I say to myself.

[chelsea35] 26/10/2017 14:46

Well it is your club house Lozan, indeed a very familiar odour.